Home » Newsletters » BioWorld Asia

BioWorld Asia

Aug. 16, 2000

View Archived Issues

Compugen Completes $50M IPO To Fund Bioinformatics Platform

Oxford Biomedica Establishing Genomics Unit With Financing

Genetically Engineered Fungus Aids Cephalosporin Production

Graffinity Seeks DM50M To Fund Array-Aided Discovery

EuropaBio Names Schepens As New Secretary-General

Lion Raises $181M In Germany, U.S. Via Initial Public Offering

Other News To Note

Evolutec Completes #2.7M Round To Fund Immunotherapy Program

Protherics Begins Contracting DockCrunch Screening System

Israeli Group Using Naked DNA Vaccine For Autoimmune Research

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 31, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026